The popularity of at-home COVID tests has amplified calls from health researchers and diagnostic companies to make testing similarly routine for sexually transmitted diseases. But FDA guidelines are lagging.
The fame of at-home COVID tests has amplified calls from the public health sector and diagnostic companies to make home testing routine for sexually transmitted diseases. But FDA guidelines are lagging.